Skip to main content Skip to menu Skip to footer
Home
  • Who we are
  • Contact Us
  • Journalists
    • Patients and relatives
    • Donors
    • Researchers
    • Students
    • Caregivers
    • TechTransfer
Search
Directory of Doctors
  • FR
  • EN
Make a donation
  • Press Release
    • 2002-2022: DOSIsoft delivering 20 years of Innovation
    • Epigenetic treatments: New allies for chemotherapies?
    • Lung cancer: a new treatment combining immunotherapies and chemotherapy reduces risk of recurrence and death by almost 40%
    • Institut Curie’s key progress for the future of oncology
    • Biomunex and Institut Curie pursue strategic collaboration for development of disruptive non-conventional T cell redirection approach to treating cancer
    • Institut Curie equips its surgeons and radiologists with AVATAR MEDICAL’s virtual reality medical image solution
    • Retinoblastoma: an ambitious project to preserve children’s sight
    • Institut Curie celebrates the centenary of Marie Curie’s trip to the United States
    • Egle Therapeutics raises 40 million € Series Ato develop First-In-Class T-regulatory cells therapies based on Treg-starvers
    • PEP-Therapy and Institut Curie announce first patients dosed in Phase I clinical trial of PEP-010 for the treatment of advanced solid tumors
    • New startup Aglaia Therapeutics raises €4M in seed funding to overcome resistance in oncology targeted therapies
    • Research / Breast cancers: ruptures in cell nuclei promotes tumor invasion
    • Research / FROM YELLOW TO WHITE AND BACK AGAIN: THE SECRET TO THE SPIDER CRAB’S COLOR CHANGES
    • Prof. Steven Le Gouill, new Director of the Hospital Group at Institut Curie
    • Accelerating the pace of pediatric oncology research and innovating at Institut Curie, to better care for young patients
    • Institut Curie applauds the €75 million fundraising achieved by its spin-off Mnemo Therapeutics
    • Nanomedicine and new targeted therapies: the advances of Institut Curie at the ASCO 2021 Meeting
    • LEBANON: Institut Curie steps up its support in oncology
    • “Flash" radiotherapy: another step towards clinical applications for Institut Curie and SIT
    • OncoDNA and Institut Curie test the clinical utility of personalized liquid biopsy in head and neck cancers
    • PEP-Therapy and Institut Curie granted approval from ANSM to start first-in-human clinical trial of PEP-010 for the treatment of advanced solid tumors
    • Onxeo Enters Clinical Research Agreement with Institut Curie to Conduct a phase 1b/2 Clinical Trial of AsiDNA™ in combination with radiotherapy for Treatment of High-Grade Glioma Relapse in Children
    • Autoimmune and inflammatory diseases associated with primary immune deficiencies
    • Keeping Sperm Cells on Track
    • Covid-19: biological bait in the form of vesicles to stop infection by the SARS-CoV-2 virus
    • COVID-19: early results of a large-scale study on the immune response against SARS-CoV-2 conducted with the help of Institut Curie staff
    • Institut Curie and Google initiate a research collaboration using artificial intelligence (AI) for the analysis of complex transcriptomic and epigenetics data
    • Intestinal Health : Macrophages lead the conversation between the microbiota and the colon
    • Cell multiplication : measuring up
    • Iron-mediated cancer cell activity: a new regulation mechanism
    • APPOINTMENT: Alain Puisieux, new director of Institut Curie Research Center
    • Institut Curie names Intel lead partner...
    • Institut Curie and Pierre Fabre initiate a novel partnership in immuno-oncology
    • Servier and Institut Curie extend duration and scope of partnership
  • Understanding cancer
Breadcrumb
  1. Institut Curie
  2. Donors

Understand cancer

Consultation patient
Breast cancer: everything
Francois Doz
Childhood cancers
Sebastian Amigorena
Immunotherapy against
Gudrun Schleiermacher
Retinoblastoma
Dr Sylvie Bonvalot
Sarcomas
Nathalie Cassoux
Uveal melanoma
Remi Dendale
Proton therapy
Gilles Crehange
Developing the
Consultation Nicolas Girard
Lung cancer
Sign up to our Newsletter
Join us
Follow us
  • facebook
  • twitter
  • linkedin
  • instagram
Patients and relatives
  • Our hospitals
  • Adult care
  • International patients
  • What is a clinical trial?
  • Care News
Access this area
Donors
  • Who we are
  • Understand cancer
  • Support us
  • Strategic priorities
  • Annual report
  • Research News
Access this area
Researchers
  • Research Center
  • Thematic areas of research
  • Research Units
  • Research Teams
  • Core Facilities
  • Seminars
  • Programs and partnerships
  • Training
  • Join us
  • Research News
Access this area
Students
  • Courses
  • The hospital
  • The Research Center
  • Collaborations
  • ADIC
  • Training News
Access this area
Caregivers
  • Refer a patient
  • Understanding cancer
  • Our expertise
  • Our hospitals
  • Contact Us
  • Care News
Access this area
Journalists
  • Press Release
  • Understanding cancer
Access this area
TechTransfer
  • About us
Access this area
  • Copyright © 2022
  • Contact and Access
  • Contact Us
  • Directory
  • Join us
  • Legal Notice
  • Personal data protection charter